Terry Litchfield, MPA, CPC
Patient Advocate & Dialysis Care Expert
Terry Foust Litchfield brings over 30 years of experience in dialysis care, patient advocacy, and healthcare administration. Specializing in dialysis vascular access and patient-centered care, she has played a pivotal role in shaping Medicare policy, advancing chronic kidney disease treatments, and driving innovation in dialysis access outside hospital settings.
Professional Overview
Terry Foust Litchfield is a patient advocate and dialysis care expert with over three decades of experience. As a co-founder of Lifeline Vascular Access, she led efforts to provide dialysis care outside traditional hospital settings, revolutionizing access for chronic kidney disease (CKD) patients. Terry’s deep knowledge of healthcare administration and her work with regulatory bodies like CMS and FDA has improved patient outcomes and policies for ESRD treatments. Her commitment to patient engagement and outcomes research has positioned her as a recognized leader in renal care.
30+ years of experience in healthcare administration and dialysis care.
Co-founder of Lifeline Vascular Access, pioneering dialysis access care outside hospitals.
Expertise in patient advocacy and regulatory affairs (CMS, FDA).
Proven track record of shaping healthcare policies for end-stage renal disease (ESRD).
Focused on outcomes research and patient-centered care for CKD patients.
Terry has dedicated her career to advocating for renal patients and advancing dialysis care. As a co-founder of Lifeline Vascular Access, she helped develop outpatient dialysis access solutions, enabling more patients to access care outside of hospitals. Her expertise spans policy advocacy, regulatory affairs, and patient engagement, shaping Medicare policies and ensuring better treatment options for patients with chronic kidney disease (CKD). Terry’s hands-on approach and research have made her a key figure in improving dialysis outcomes and patient satisfaction.
Championing Patient-Centered Dialysis Solutions
Key Contributions & Achievements
Terry has been at the forefront of dialysis care innovation for over 30 years. From regulatory leadership at CMS and the FDA to co-founding Lifeline Vascular Access, she has influenced Medicare policies and treatment options that benefit dialysis patients. Her outcomes research continues to shape patient-centered care practices and improve satisfaction with dialysis treatments. Through her advocacy work, Terry has been instrumental in developing better solutions for vascular access, ensuring that patients receive the best possible care, both inside and outside hospital settings.
Co-founded Lifeline Vascular Access, pioneering outpatient dialysis care.
Shaped Medicare policy for dialysis care and end-stage renal disease (ESRD) treatment.
Led regulatory efforts with CMS and FDA to improve dialysis devices and treatments.
Advocated for patient-centered care and improved patient satisfaction in dialysis.
Authored publications on dialysis vascular access, patient engagement, and CKD management.
Patient Advocacy & Engagement: Shaping strategies to improve patient satisfaction and engagement in dialysis care.
Dialysis Vascular Access: Expertise in the development and management of vascular access for dialysis patients.
Regulatory Affairs: Leading CMS and FDA efforts for dialysis device and treatment approvals.
Outcomes Research & Disease Management: Advancing disease management and outcomes research to improve quality of life for dialysis patients.
Healthcare Program Planning: Extensive experience in planning healthcare programs aimed at improving patient outcomes.
Areas of Expertise
Get in touch
Let us guide your innovation to success.
Contact Echelon Development Group today to learn how we can support your project at every stage.